Stroke Gene Discovery Increases Hope for New Treatments

The discovery of a new gene called FOXF2, which is responsible for stroke and dementia increases hope for developing potential new treatments.

A gene called FOXF2, which increases the risk of having a stroke has been identified. It is hoped that this discovery may improve the understanding of the condition to develop new treatments.

The gene FOXF2 increases the risk of having a stroke due to blocked small blood vessels in the brain.

Here's Why Stroke Victims Suffer From Spelling Impairment
Stroke victims with long-term memory difficulties cannot remember how to spell words they once knew and tend to make educated guesses.

‘A new gene called ‘FOXF2’ increases the risk of having a stroke due to small vessel disease in the brain.’

Previous studies have found genes that cause hardening of the arteries, known as atherosclerosis, and those behind blood clots that cause a form of the disease called an ischemic stroke. A different gene has been associated with hemorrhagic stroke or bleeding into the brain.

Professor Sudha Seshadri, of Boston University, said, "Our research has identified a gene affecting another type of ischemic stroke, due to small vessel disease, and also suggests some genes may be associated with both ischemic and hemorrhagic stroke and may act through a novel pathway affecting pericytes, a type of cell in the wall of small arteries and capillaries.”

"Unraveling the mechanisms of small vessel disease is essential for the development of therapeutic and preventive strategies for this major cause of stroke."

New Imaging Technique Gives A Clear Picture of Stroke Damage
During an ischemic stroke, harmful enzymes called gelatinase become overactive in areas of the brain where blood flow is cut off, and causes brain damage.

Small vessel disease not only causes stroke but is also a major contributor to dementia gait problems and depression.

Seshadri added, "Hence, it is exciting we are beginning to better understand the cause of this very important and poorly understood type of stroke."

New Stroke Treatment Combines Injectable Clot-Busting Nanotherapeutic With Intra-Arterial Device
The new treatment has a lower risk microclot formation when compared to the currently used procedure - stent-retriever thrombectomy.

The findings are published in the journal The Lancet Neurology.

Source-Medindia

Young African-Americans Often Underestimate Stroke Risk
One-third of strokes occur in people under the age of 65. Young African-Americans have a 50% higher chance of having a stroke than Caucasians of the same age.